Phibro Animal Health (NASDAQ:PAHC) Declares Quarterly Dividend

Phibro Animal Health Corporation, a global diversified animal health and nutrition company, announced on February 4, 2025, the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock. The dividend will be payable on March 26, 2025, to stockholders of record as of the close of business on March 5, 2025.

The press release issued by Phibro Animal Health Corporation regarding the dividend can be accessed as Exhibit 99.1 in the Current Report on Form 8-K, which also includes additional details related to the declaration.

Phibro Animal Health Corporation aims to be a trusted partner for livestock producers, farmers, veterinarians, and consumers involved in raising or caring for farm and companion animals. The company provides solutions to assist these stakeholders in maintaining and enhancing the health of their animals. For more information about Phibro Animal Health Corporation, interested parties can visit www.pahc.com.

This announcement underscores Phibro Animal Health Corporation’s commitment to delivering value to its shareholders while maintaining a focus on animal health and nutrition solutions.

Contact information for Phibro Animal Health Corporation:
Glenn David
Chief Financial Officer
Phone: +1-201-329-7300
Email: [email protected]

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Phibro Animal Health’s 8K filing here.

About Phibro Animal Health

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

See Also